{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["ddca8b4f-bb5c-40d8-93a0-e9b17e11b9ca", "Q1", 312576, "AMERICAN CANCER SOCIETY, CALIFORNIA DIVISION, INC.", 183995, "AMERICAN CANCER SOCIETY CALIFORNIA DIVISION INC", 2012, "first_quarter", "2012-04-19T16:56:41.317000-04:00", 360000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/ddca8b4f-bb5c-40d8-93a0-e9b17e11b9ca/\", \"filing_uuid\": \"ddca8b4f-bb5c-40d8-93a0-e9b17e11b9ca\", \"filing_type\": \"Q1\", \"filing_type_display\": \"1st Quarter - Report\", \"filing_year\": 2012, \"filing_period\": \"first_quarter\", \"filing_period_display\": \"1st Quarter (Jan 1 - Mar 31)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/ddca8b4f-bb5c-40d8-93a0-e9b17e11b9ca/print/\", \"filing_document_content_type\": \"text/html\", \"income\": null, \"expenses\": \"360000.00\", \"expenses_method\": \"b\", \"expenses_method_display\": \"Method B - Reporting amounts under section 6033(b)(8) of the Internal Revenue Code\", \"posted_by_name\": \"Allen Lum, Real Estate Manager/Tax Accountant\", \"dt_posted\": \"2012-04-19T16:56:41.317000-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": \"United States of America\", \"registrant_address_1\": \"1710 WEBSTER STREET\", \"registrant_address_2\": null, \"registrant_different_address\": false, \"registrant_city\": \"OAKLAND\", \"registrant_state\": \"CA\", \"registrant_zip\": \"94612\", \"registrant\": {\"id\": 312576, \"url\": \"https://lda.senate.gov/api/v1/registrants/312576/\", \"house_registrant_id\": 38757, \"name\": \"AMERICAN CANCER SOCIETY, CALIFORNIA DIVISION, INC.\", \"description\": null, \"address_1\": \"1710 WEBSTER STREET\", \"address_2\": null, \"address_3\": null, \"address_4\": null, \"city\": \"OAKLAND\", \"state\": \"CA\", \"state_display\": \"California\", \"zip\": \"94612\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"ALLEN LUM\", \"contact_telephone\": \"\", \"dt_updated\": \"2022-04-06T16:06:36.044665-04:00\"}, \"client\": {\"id\": 183995, \"url\": \"https://lda.senate.gov/api/v1/clients/183995/\", \"client_id\": 12, \"name\": \"AMERICAN CANCER SOCIETY CALIFORNIA DIVISION INC\", \"general_description\": null, \"client_government_entity\": false, \"client_self_select\": true, \"state\": \"CA\", \"state_display\": \"California\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": \"CA\", \"ppb_state_display\": \"California\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2007-08-14\"}, \"lobbying_activities\": [{\"general_issue_code\": \"TOB\", \"general_issue_code_display\": \"Tobacco\", \"description\": \"Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) legislation regarding Congressional review/approval of regulations, including H.R. 10, the Regulations from the Executive in Need of Security Act of 2011; (4) Framework Convention on Tobacco Control (FCTC); and (5) issues relating to NIH reorganization.  Legislation includes H.R. 3186 and S. 1706, Smuggled Tobacco Prevention Act; H.R. 3382, Smoke-Free Federal Building Act; S. 1403, IDEA Full Funding Act; And H.R. 65: Candy Tobacco Tax Parity Act of 2011.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 17612, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KEVIN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"KEANE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"HCR\", \"general_issue_code_display\": \"Health Issues\", \"description\": \"Issues relating to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R. 2941 and S. 3493; HR 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; HR 4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Protection and Affordable Care Act of 2010; S. 1064, the Sun Act; S. 965, the Family Act; HR 2954, Health Equity and Accountability Act of 2011; and HR 2077, the MLR Repeal Act; H.R. 2245 and S. 296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, and issues relating to the ongoing national shortage of cancer drugs.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 17612, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KEVIN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"KEANE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"MMM\", \"general_issue_code_display\": \"Medicare/Medicaid\", \"description\": \"Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid, including S. 868 and H.R. 1683, the State Flexibility Act (MOE); and matters under consideration by the Joint Select Committee on Deficit Reduction.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 17612, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KEVIN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"KEANE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"BUD\", \"general_issue_code_display\": \"Budget/Appropriations\", \"description\": \"Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, and international health; and matters under consideration by the Joint Select Committee on Deficit Reduction.  Legislation includes H. Con. Res. 34, establishing the budget for the US Government for FY 2012; S. 1599, legislation including draft House text of legislation making appropriations for L-HHS FY 12; H.R. 2055 and S. 3671, Consolidated Appropriations Act of 2012.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 17612, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KEVIN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"KEANE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["ddca8b4f-bb5c-40d8-93a0-e9b17e11b9ca"], "units": {}, "query_ms": 53.73218399472535, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}